Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 616522Generated: October 26, 2026

Hydrochloric Acid → (6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

https://huagongshe.com/reaction/616522

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
Reactant5'-AtpHCID 5957—
ReactantPotassium HydroxideHCID 14797—
ReactantCarbamic acid, monoanhydride with phosphoric acid, ion(2-)HCID 3423467—
ReactantMagnesium ChlorideHCID 5360315—
Reactant(6R,7R)-3-Hydroxymethyl-7-[2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylic acidHCID 54170549—
CatalystManganese(2+) dichlorideHCID 10313134—
SolventAcetic AcidHCID 176—
Product(6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidHCID 41375—

Reaction Steps

Concentrated enzyme (0.5 ml) was incubated at 28° in a final volume of 1.0 ml water containing (6R,7R)-3-hydroxymethyl-7-[2-methoxyimino-2-(fur-2-yl) acetamido]-ceph-3-em-4-carboxylic acid (syn-isomer) (0.1 μmole), carbamoyl phosphate (3 μmoles), ATP (1 μmole), magnesium chloride (1 μmole), manganese chloride (1 μmole) & pipes buffer (50 μmoles) adjusted to pH 6.0 with potassium hydroxide. After 2 hr the reaction was stopped by the addition of acetic acid (20 μl). The pH was then adjusted to 2.0 with M hydrochloric acid and the precipitated protein was centrifuged off. The supernatant was extracted with ethylacetate (2.5 ml). The organic phase was collected and evaporated to dryness. The cephalosporins it contained were then separated by hplc [100 mm × 5 mm diam. column Partisil 5 eluted at 1500 psi with chloroform:methanol: 90% formic acid (25:2:1 v/v) saturated with water] and were detected by their absorption at 270 nm. Their retention time was compared with standard samples. The size of the U.V. absorbing peaks showed that 20% of the cephalosporin starting material had been converted to title compound.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04075061
Source datasetuspto-grants-1978_02
ORD IDord-5205b90a00a74d7db9dec97102f859d9
Source noteuspto-grants-1978_02